SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001140361-18-019161
Filing Date
2018-04-20
Accepted
2018-04-20 16:30:20
Documents
1
Period of Report
2018-06-01
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14C s002202x1_def14c.htm DEF 14C 938306
  Complete submission text file 0001140361-18-019161.txt   939336
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-38137 | Film No.: 18767086
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1